We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-5.11%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$10.4B
AUM Growth
-$929M
Cap. Flow
-$275M
Cap. Flow %
-2.65%
Top 10 Hldgs %
43.03%
Holding
1,068
New
166
Increased
266
Reduced
450
Closed
162

Sector Composition

Rank Sector Weight
1 Energy 50.72%
2 Financials 11.42%
3 Technology 6.62%
4 Healthcare 4.85%
5 Consumer Discretionary 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSI icon
326
Motorola Solutions
MSI
$69.4B
$1.91M 0.02%
8,199
+2,299
+39% +$533K
ATRA icon
327
Atara Biotherapeutics
ATRA
$71.2M
$1.86M 0.02%
4,155
-274
-6% -$98.2K
KDMN
328
DELISTED
Kadmon Holdings, Inc.
KDMN
$1.85M 0.02%
212,448
-14,067
-6% -$80.1K
INO icon
329
Inovio Pharmaceuticals
INO
$79.8M
$1.85M 0.02%
21,486
-1,349
-6% -$135K
MUX icon
330
McEwen Inc
MUX
$1.03B
$1.83M 0.02%
175,816
+9,350
+6% +$107K
TVTX icon
331
Travere Therapeutics
TVTX
$5.33B
$1.8M 0.02%
74,411
-5,214
-7% -$95.8K
NWS icon
332
News Corp Class B
NWS
$16.4B
$1.72M 0.02%
74,186
PGR icon
333
Progressive
PGR
$124B
$1.71M 0.02%
18,873
-1,470
-7% -$140K
REPL icon
334
Replimune Group
REPL
$814M
$1.7M 0.02%
57,322
-4,065
-7% -$132K
GOOGL icon
335
Alphabet (Google) Class A
GOOGL
$3.91T
$1.67M 0.02%
12,500
-1,780
-12% -$242K
STEP icon
336
StepStone Group
STEP
$3.48B
$1.66M 0.02%
39,000
-10,100
-21% -$447K
ZYME icon
337
Zymeworks
ZYME
$1.68B
$1.65M 0.02%
56,851
-3,562
-6% -$118K
PLD icon
338
Prologis
PLD
$138B
$1.64M 0.02%
13,059
-1,060
-8% -$138K
DPZ icon
339
Domino's
DPZ
$11B
$1.64M 0.02%
3,427
-190
-5% -$96.2K
MDGL icon
340
Madrigal Pharmaceuticals
MDGL
$12.6B
$1.62M 0.02%
20,338
-1,406
-6% -$121K
UNH icon
341
UnitedHealth
UNH
$382B
$1.62M 0.02%
4,146
-300
-7% -$124K
SGMO
342
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.6M 0.02%
178,133
-11,385
-6% -$113K
SBUX icon
343
Starbucks
SBUX
$118B
$1.59M 0.02%
14,460
+590
+4% +$69.1K
BLUE
344
DELISTED
bluebird bio
BLUE
$1.58M 0.02%
6,395
-425
-6% -$121K
MGNX icon
345
MacroGenics
MGNX
$235M
$1.57M 0.02%
74,897
-4,180
-5% -$101K
ARCT icon
346
Arcturus Therapeutics
ARCT
$157M
$1.54M 0.01%
32,259
-2,406
-7% -$108K
YMAB
347
DELISTED
Y-mAbs Therapeutics
YMAB
$1.52M 0.01%
53,409
-3,977
-7% -$125K
PDM
348
Piedmont Realty Trust
PDM
$1.22B
$1.52M 0.01%
87,041
-3,685
-4% -$67.1K
CHRS icon
349
Coherus Oncology
CHRS
$217M
$1.51M 0.01%
93,732
-6,038
-6% -$88.5K
ARQT icon
350
Arcutis Biotherapeutics
ARQT
$3.42B
$1.47M 0.01%
61,578
-4,546
-7% -$104K

Similar funds

ALPS Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, ALPS Advisors held 1,068 positions worth $10.4B, down 8.2% from $11.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

ALPS Advisors's Q3 2021 filing shows 166 new, 266 increased, 450 reduced and 162 closed positions. Its largest new stake was Stem: 59,506 shares worth $28.4M. The largest sale was MPLX, an estimated $69.6M.

By sector, the portfolio is most concentrated in Energy at 51% of assets, down from 53% a quarter earlier, followed by Financials and Technology.

  • ALPS Advisors's largest Q3 2021 buy was Stem: 59,506 shares worth $28.4M.
  • ALPS Advisors added most to ENLINK MIDSTREAM, LLC in Q3 2021, an estimated $39.9M increase.
  • ALPS Advisors's biggest Q3 2021 reduction was MPLX, cutting an estimated $69.6M.
  • ALPS Advisors fully exited Universal Display in Q3 2021, selling an estimated $47.2M.
  • ALPS Advisors's ten largest holdings make up 43% of its $10.4B portfolio in Q3 2021.
  • ALPS Advisors opened 166 new positions and closed 162 in Q3 2021.
  • ALPS Advisors's portfolio value fell 8.2% quarter-over-quarter to $10.4B.

Based on ALPS Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.